Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Press Releases Study Finds ACD/Labs pKa Predictions to be Most Accurate
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

Study Finds ACD/Labs pKa Predictions to be Most Accurate

by Tara Sinclair last modified 04-07-08 12:52 AM

A recently published study comparing pKa prediction tools found ACD/pK sub>a</sub> to be the best based on several criteria.

Study Finds ACD/Labs pKa Predictions to be Most Accurate

ACD/pKa DB

Toronto, Canada (March 18, 2007)—Researchers at Pardubice University in the Czech Republic published a study in the December 2007 issue of Analytical and Bioanalytical Chemistry evaluating the accuracy and predictive power of four pK sub>a prediction software tools (including commercially available and free packages). Their conclusion, after in-depth statistical analysis, was that ACD/pK sub>a DB provides the most accurate predictions.

Modern chemistry relies heavily on the modeling of chemical and biological parameters, based on the prediction of molecular properties. Not least because in-silico predictions help minimize the cost associated with experimental measurement. While tools for the prediction of a variety of molecular properties are available, prediction of one property in particular, pK sub>aa—measuring the degree of dissociation of a compound in solution—was chosen by the researchers due to its impact on pharmacology, and the effect of chemicals in the environment—to name but two areas.

The study, carried out by M. Meloun and S. Bordovska and entitled 'Benchmarking and validating algorithms that estimate pK sub>a values of drugs based on their molecular structure' (Anal. Bioanal. Chem., 389: 1267–1291, 2007) compares predicted values to experimental results for three sets of compounds. Using a linear regression analysis technique (fully defined in the paper) they concluded that ACD/pK sub>a DB provided the most accurate predicted values compared to the other packages, showing the best results in six different statistical characteristics.

All four of the software packages compared use of a fragment-based approach to prediction, meaning that the software consists of a database of chemical structure fragments, and uses a proprietary algorithm to calculate predicted values for whole molecules based on the fragments it contains. Therefore when comparing software, one must also take into consideration the size of the fragment database, and whether there is the ability to add one’s own experimental data to the database, not to mention factors such as reliability, commitment of the manufacturer, and the availability of advanced features.

ACD/pK sub>a DB uses Hammett equations derived from a library of ~14,000 highly curated compounds—one of the largest internal databases of any commercially available pK sub>a predictor—to predict aqueous pK sub>a. ACD/pK sub>a DB also offers two methods for adding proprietary experimental data, to improve prediction accuracy for novel chemical space. In addition, two reference databases are available that offer quick look-up of published data—one contains >31,000 experimental pK sub>a values for approximately 16,000 compounds in aqueous solutions; the other provides experimental data for more than 2000 molecules in non-aqueous solvents. Since the introduction of the first pK sub>a predictor from ACD/Labs in 1995 there has been continual development and enhancement of the software which is currently used by the majority of pharmaceutical and API companies worldwide.

For more information about pK sub>a prediction or ACD/Labs Physicochemical prediction software, visit our website at www.acdlabs.com/physchem/

About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Founded in 1994, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 145 dedicated individuals whose continual efforts carry ACD/Labs' innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products is available at www.acdlabs.com.
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: